Li, Xi <br/><br/>
Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth.  [electronic resource] 

 -  Cancer gene therapy  Feb 2003 
 - 105-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0929-1903 
<br/><br/><label>Standard No.: </label>10.1038/sj.cgt.7700530  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Anti-Bacterial Agents--pharmacology<br/>Apoptosis--genetics<br/>Bifidobacterium--drug effects<br/>Cell Division--drug effects<br/>Cell Hypoxia<br/>Collagen--administration & dosage<br/>Drug Delivery Systems<br/>Drug Resistance, Bacterial--genetics<br/>Endostatins<br/>Gene Expression<br/>Genetic Therapy--methods<br/>Liver Neoplasms, Experimental--microbiology<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Peptide Fragments--administration & dosage<br/>Plasmids--genetics<br/>Polymerase Chain Reaction--methods